Other words: Management is gone for a reason and we no longer trust anything we were told.
They are waiting for new management to release a "honest" report of where things stand.
Hopefully UNS will have success in finding a CEO that, among many attributes, has credibility among the analyst community.
I still think Piper's initiation report is still a good road map, especially since Medimmune and AMGN were not mentioned, however it is the timelines that might be problematic.
"We Wait. RRMan"
UNS Price at posting:
19.5¢ Sentiment: Buy Disclosure: Held